Genekam developed potential therapeutic human anitbodies against Chlamydia
Genekam has developed a number of new breast cancer tumor markers from blood samples
Usually we are composed of 3 or 4 members coming from different scientific fields to create innovative solutions in the field of medicine. Here are experiences of some of our team members:
Member 1: Experience in virology, immunology and stem cells along with the field of management and marketing. Long experience in creating immunotherapies.
Member 2: Experience in Stemcells including cancer stem cells, fluorescent techniques like flow cytometry and molecular biology